[1]
Leung AKC,Leung AAM,Wong AHC,Hon KL, Travelers' Diarrhea: A Clinical Review. Recent patents on inflammation
[PubMed PMID: 31084597]
[2]
Koulinska I,Riester K,Chalkias S,Edwards MR, Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study. Clinical therapeutics. 2018 Dec;
[PubMed PMID: 30447891]
Level 1 (high-level) evidence
[3]
Hailey FJ,Newsom JH, Evaluation of bismuth subsalicylate in relieving symptoms of indigestion. Archives of internal medicine. 1984 Feb;
[PubMed PMID: 6365007]
[5]
Patel AR,Oheb D,Zaslow TL, Gastrointestinal Prophylaxis in Sports Medicine. Sports health. 2018 Mar/Apr;
[PubMed PMID: 28952896]
[6]
de Boer WA,Tytgat GN, Regular review: treatment of Helicobacter pylori infection. BMJ (Clinical research ed.). 2000 Jan 1;
[PubMed PMID: 10617524]
[7]
Testerman TL,Morris J, Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World journal of gastroenterology. 2014 Sep 28;
[PubMed PMID: 25278678]
[8]
Miehlke S,Bayerdörffer E,Graham DY, Treatment of Helicobacter pylori infection. Seminars in gastrointestinal disease. 2001 Jul;
[PubMed PMID: 11478749]
[9]
Chey WD,Leontiadis GI,Howden CW,Moss SF, ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American journal of gastroenterology. 2017 Feb;
[PubMed PMID: 28071659]
[10]
Rendi-Wagner P,Kollaritsch H, Drug prophylaxis for travelers' diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 Mar 1;
[PubMed PMID: 11803509]
[11]
Steffen R, Worldwide efficacy of bismuth subsalicylate in the treatment of travelers' diarrhea. Reviews of infectious diseases. 1990 Jan-Feb;
[PubMed PMID: 2406861]
[13]
Goldman RD, Bismuth salicylate for diarrhea in children. Canadian family physician Medecin de famille canadien. 2013 Aug;
[PubMed PMID: 23946025]
[14]
Pitz AM,Park GW,Lee D,Boissy YL,Vinjé J, Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut microbes. 2015;
[PubMed PMID: 25901890]
[15]
Nwokolo CU,Mistry P,Pounder RE, The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Alimentary pharmacology
[PubMed PMID: 2104082]
[16]
Sheele J,Cartowski J,Dart A,Poddar A,Gupta S,Stashko E,Ravi BS,Nelson C,Gupta A, Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera. Pathogens and global health. 2015 Sep;
[PubMed PMID: 26260354]
[18]
Walsh JH,Peterson WL, The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. The New England journal of medicine. 1995 Oct 12;
[PubMed PMID: 7666920]
[19]
McNulty CA, Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori. Reviews of infectious diseases. 1990 Jan-Feb;
[PubMed PMID: 2406863]
[20]
Koletzko S,Jones NL,Goodman KJ,Gold B,Rowland M,Cadranel S,Chong S,Colletti RB,Casswall T,Elitsur Y,Guarner J,Kalach N,Madrazo A,Megraud F,Oderda G, Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. Journal of pediatric gastroenterology and nutrition. 2011 Aug;
[PubMed PMID: 21558964]
Level 1 (high-level) evidence
[21]
Choi J,Jang JY,Kim JS,Park HY,Choe YH,Kim KM, Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. Journal of Korean medical science. 2006 Dec;
[PubMed PMID: 17179683]
[22]
Castelli F,Saleri N,Tomasoni LR,Carosi G, Prevention and treatment of traveler's diarrhea. Focus on antimicrobial agents. Digestion. 2006;
[PubMed PMID: 16498259]
[23]
Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, DuPont HL, Bia FJ, Fischer PR, Ryan ET, Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Dec 15:43(12):1499-539
[PubMed PMID: 17109284]
[24]
Riddle MS,DuPont HL,Connor BA, ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. The American journal of gastroenterology. 2016 May;
[PubMed PMID: 27068718]
[25]
Vilaichone RK,Prapitpaiboon H,Gamnarai P,Namtanee J,Wongcha-um A,Chaithongrat S,Mahachai V, Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area. Asian Pacific journal of cancer prevention : APJCP. 2015;
[PubMed PMID: 26320500]
[26]
Borbinha C,Serrazina F,Salavisa M,Viana-Baptista M, Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate. BMC neurology. 2019 Aug 29;
[PubMed PMID: 31464594]
[27]
Sainsbury SJ, Fatal salicylate toxicity from bismuth subsalicylate. The Western journal of medicine. 1991 Dec;
[PubMed PMID: 1812638]
[28]
Rao G,Aliwalas MG,Slaymaker E,Brown B, Bismuth revisited: an effective way to prevent travelers' diarrhea. Journal of travel medicine. 2004 Jul-Aug;
[PubMed PMID: 15541227]
[29]
Lambert JR, Pharmacology of bismuth-containing compounds. Reviews of infectious diseases. 1991 Jul-Aug;
[PubMed PMID: 1925310]
[30]
Hogan DB,Harbidge C,Duncan A, Bismuth Toxicity Presenting as Declining Mobility and Falls. Canadian geriatrics journal : CGJ. 2018 Dec;
[PubMed PMID: 30595782]